PMID- 29041842 OWN - NLM STAT- MEDLINE DCOM- 20180813 LR - 20191210 IS - 1532-4281 (Electronic) IS - 1079-9893 (Linking) VI - 38 IP - 1 DP - 2018 Feb TI - Identifying novel small molecule antagonists for mLST8 protein using computational approaches. PG - 1-11 LID - 10.1080/10799893.2017.1387920 [doi] AB - Mammalian lethal with SEC13 protein 8 (mLST8), is an indispensable protein subunit of mammalian target of rapamycin (mTOR) signaling pathway that interacts with the kinase domain of mTOR protein, thereby stabilizing its active site. Experimental studies reported the over expression of mLST8 in human colon and prostate cancers by activation of both mTORC1/2 complexes and subsequent downstream substrates leading to tumor progression. Considering its role, targeting mLST8 protein would be a therapeutic approach against tumor progression in colon and prostate cancers. Hence, using in silico structure based drug design approach, the comparative binding patterns of 1,1'-binapthyl-2,2'diol (BINOL), 1-(2-carboxynaphth-1yl)-2-naphthoic acid (SCF-12) and their analogs in the cavity of mLST8 were explored. ADME and binding energy calculations led to the identification of five compounds with favorable Glide (G) scores and implicated the importance of Asn132 and Gln225 as key binding residues. Molecular dynamics (MD) simulations and free energy landscape (FEL) approaches helped in elucidating the binding mechanism and suggested the possibility of ligands 1-3 namely, ZINC01765622, ZINC62723702 and ZINC02576980 to be promising antagonists for mLST8. Thus, this study substantiates the prospect of targeting mLST8 protein using potent hits which could hinder tumor progression in colon and prostate cancers. FAU - Sapam, Tuleshwori Devi AU - Sapam TD AD - a Centre for Bioinformatics, School of Life Sciences , Pondicherry University , Puducherry , India. FAU - Velmurugan Ilavarasi, Anbumani AU - Velmurugan Ilavarasi A AD - a Centre for Bioinformatics, School of Life Sciences , Pondicherry University , Puducherry , India. FAU - Palaka, Bhagath Kumar AU - Palaka BK AD - a Centre for Bioinformatics, School of Life Sciences , Pondicherry University , Puducherry , India. FAU - Elumalai, Elakkiya AU - Elumalai E AD - a Centre for Bioinformatics, School of Life Sciences , Pondicherry University , Puducherry , India. FAU - Kanika, Nirmala Devi AU - Kanika ND AD - b Department of Biochemistry , S.V. University , Tirupati , India. FAU - Ampasala, Dinakara Rao AU - Ampasala DR AD - a Centre for Bioinformatics, School of Life Sciences , Pondicherry University , Puducherry , India. LA - eng PT - Journal Article DEP - 20171017 PL - England TA - J Recept Signal Transduct Res JT - Journal of receptor and signal transduction research JID - 9509432 RN - 0 (BINOL, naphthol) RN - 0 (Carboxylic Acids) RN - 0 (MLST8 protein, human) RN - 0 (Naphthalenes) RN - 0 (Naphthols) RN - 0 (mTOR Associated Protein, LST8 Homolog) RN - 2NIV4O66BH (1-naphthoic acid) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) SB - IM MH - Carboxylic Acids/chemistry MH - Catalytic Domain/drug effects MH - Colonic Neoplasms/*drug therapy MH - Computer Simulation MH - Drug Design MH - Humans MH - Male MH - Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors/chemistry MH - Molecular Dynamics Simulation MH - Molecular Targeted Therapy MH - Naphthalenes/chemistry MH - Naphthols/*chemistry/pharmacology MH - Prostatic Neoplasms/*drug therapy MH - Protein Binding MH - Signal Transduction/drug effects MH - mTOR Associated Protein, LST8 Homolog/antagonists & inhibitors/*chemistry OTO - NOTNLM OT - Colon cancer OT - free energy landscape OT - mLST8 OT - mTOR OT - mTOR signaling pathway OT - molecular docking OT - molecular dynamics simulations OT - prostate cancer EDAT- 2017/10/19 06:00 MHDA- 2018/08/14 06:00 CRDT- 2017/10/19 06:00 PHST- 2017/10/19 06:00 [pubmed] PHST- 2018/08/14 06:00 [medline] PHST- 2017/10/19 06:00 [entrez] AID - 10.1080/10799893.2017.1387920 [doi] PST - ppublish SO - J Recept Signal Transduct Res. 2018 Feb;38(1):1-11. doi: 10.1080/10799893.2017.1387920. Epub 2017 Oct 17.